TITLE

EDITOR'S QUIZ: GI SNAPSHOT

PUB. DATE
October 2007
SOURCE
Gut;Oct2007, Vol. 56 Issue 10, p1386
SOURCE TYPE
Academic Journal
DOC. TYPE
Case Study
ABSTRACT
The article presents an answer to a case study about intra-hepatic and extra-hepatic ductal dilatation with extensive extrahepatic lymphadenopathy. The histology of the lymph-node biopsy shows non-caseating histiocytic granulomata with giant cells and asteroid bodies. It shows that stains for acid-fast bacilli and fungi were negative. Sarcoidosis is a systemic inflammatory disease characterized by the formation of non-caseating granulomas.
ACCESSION #
27148467

 

Related Articles

  • The Gut Hormone Profile of Fulminant Hepatic Failure. Sullivan, S. N.; Chase, R. A.; Christofides, N. D.; Bloom, S. R.; Williams, Roger // American Journal of Gastroenterology;Oct1981, Vol. 76 Issue 4, p338 

    Twenty-five patients with fulminant hepatic failure and grade III or IV hepatic encephalopathy were studied. Plasma insulin, glucagon, pancreatic polypeptide and enteroglucagon were significantly raised. Levels of secretin and gastrin were normal, while motilin concentrations were significantly...

  • N-Acetylcysteine attenuates cerebral complications of non-acetaminophen-induced acute liver failure in mice: antioxidant and anti-inflammatory mechanisms. Bémeur, Chantal; Vaquero, Javier; Desjardins, Paul; Butterworth, Roger F. // Metabolic Brain Disease;Jun2010, Vol. 25 Issue 2, p241 

    N-acetylcysteine (NAC) is an effective antidote to treat acetaminophen (APAP)-induced acute liver failure (ALF). NAC is hepatoprotective and prevents the neurological complications of ALF, namely hepatic encephalopathy and brain edema. The protective effect of NAC and its mechanisms of action in...

  • Reversibility of hepatic encephalopathy after liver transplantation. Atluri, Dileep K.; Asgeri, Mehrdad; Mullen, Kevin D. // Metabolic Brain Disease;Mar2010, Vol. 25 Issue 1, p111 

    Until the advent of Liver transplantation, it was widely believed that Hepatic Encephalopathy (HE) was usually reversible. The exceptions were the so called “Acquired Hepatocerebral Degeneration cases” which were considered irreversible. Paradoxically, it seems, with liver...

  • Activation of Neuronal Nitric Oxide Synthase in Cerebellum of Chronic Hepatic Encephalopathy Rats is Associated with Up-regulation of NADPH-Producing Pathway. Singh, Santosh; Trigun, Surendra K. // Cerebellum;Sep2010, Vol. 9 Issue 3, p384 

    Cerebellum-associated functions get affected during mild hepatic encephalopathy (MHE) in patients with chronic liver failure (CLF). Involvement of nitrosative and antioxidant factors in the pathogenesis of chronic hepatic encephalopathy is an evolving concept and needs to be defined in a true...

  • Subclinical Hepatic Encephalopathy Predicts the Development of Overt Hepatic Encephalopathy. Romero-Gómez, Manuel; Boza, Fernando; García-Valdecasas, Maria Sierra; García, Emilio; Aguilar-Reina, José // American Journal of Gastroenterology;Sep2001, Vol. 96 Issue 9, p2718 

    OBJECTIVES: In patients with compensated liver cirrhosis the clinical repercussions of detecting subclinical hepatic encephalopathy (SHE) are unclear. We present a long-term follow-up study in cirrhotic patients to examine the relationship between SHE and subsequent episodes of overt hepatic...

  • SUBCLINICAL HEPATIC ENCEPHALOPATHY: HOW BEST TO DIAGNOSE? Chalasani, Naga; Gitlin, Norman // American Journal of Gastroenterology;May1997, Vol. 92 Issue 5, p905 

    Neuropsychological tests used for the assessment of subclinical hepatic encephalopathy (SHE) may overdiagnose SHE, because scores are usually not corrected for age. The aim of this study was to estimate the prevalence of SHE using two easily administrahle psychometric tests (Number Connection...

  • Absence of neuropsychological impairment in hyperammonaemia in healthy young adults; possible synergism in development of hepatic encephalopathy (HE) symptoms? Wilkinson, Daniel; Smeeton, Nicholas; Castle, Paul; Watt, Peter // Metabolic Brain Disease;Sep2011, Vol. 26 Issue 3, p203 

    The aetiology of minimal hepatic encephalopathy (mHE) remains unclear. It is generally accepted that hyperammonaemia plays a major role, however there are a multitude of metabolic perturbations present. To determine the contribution of hyperammonaemia to mHE symptom development, ten healthy...

  • Multi-dimensional MR spectroscopy: towards a better understanding of hepatic encephalopathy. Sarma, Manoj; Huda, Amir; Nagarajan, Rajakumar; Hinkin, Charles; Wilson, Neil; Gupta, Rakesh; Frias-Martinez, Enrique; Sayre, James; Guze, Barry; Han, Steven-Huy; Thomas, M. // Metabolic Brain Disease;Sep2011, Vol. 26 Issue 3, p173 

    Hepatic encephalopathy (HE) is normally diagnosed by neuropsychological (NP) tests. The goals of this study were to quantify cerebral metabolites, separate glutamate (Glu) from glutamine (Gln) in patients with minimal hepatic encephalopathy (MHE) as well as healthy subjects using the...

  • Predictors of Minimal Hepatic Encephalopathy in Patients with Cirrhosis. Sharma, Praveen; Sharma, Barjesh C. // Saudi Journal of Gastroenterology;Jul2010, Vol. 16 Issue 3, p181 

    Background/Aim: Minimal hepatic encephalopathy (MHE) impairs patient's daily functioning of life. Predictors of MHE in cirrhotic patients have not been evaluated. Patients and Methods: A total of 200 cirrhotic patients (Child A, 74 [37%]; Child B, 72 [36%]; Child C, 54 [27%]) were evaluated by...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics